Back
Range Cancer Therapeutics ETF Stock Price Chart
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CNCR
Range Cancer Therapeutics ETF
Last Price:
$11.14
Seasonality Move:
-1.76%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder that's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight buying pressure.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.74 | Sell |
| 20-day SMA: | 11.19 | Sell |
| 50-day SMA: | 11.84 | Sell |
| 200-day SMA: | 13.77 | Sell |
| 8-day EMA: | 2.39 | Buy |
| 20-day EMA: | 1.02 | Buy |
| 50-day EMA: | 0.42 | Buy |
| 200-day EMA: | 0.11 | Buy |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 39.51 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.71 - 12.21) | Sell |
| Bollinger Bands (100): | (11.51 - 14.29) | Sell |
Range Cancer Therapeutics ETF Technical Analysis
| Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
-
Range Cancer Therapeutics ETF share price is 10.74 while CNCR 8-day simple moving average is 10.74, which is a Sell signal.
-
The stock price of CNCR is 10.74 while Range Cancer Therapeutics ETF 20-day SMA is 11.19, which makes it a Sell.
-
Range Cancer Therapeutics ETF 50-day simple moving average is 11.84 while CNCR share price is 10.74, making it a Sell technically.
-
CNCR stock price is 10.74 and Range Cancer Therapeutics ETF 200-day simple moving average is 13.77, creating a Sell signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
28
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a SellThe current Range Cancer Therapeutics ETF [CNCR] share price is $10.74. The Score for CNCR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
10.74
Share Volume:
127
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
16.78
52-Week Low:
10.44
Sell
28
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?The Range Cancer Therapeutics ETF stock price is 10.74 USD today.
-
Will CNCR stock go up or go down?Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is Range Cancer Therapeutics ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
-
Range Cancer Therapeutics ETF share price is 10.74 while CNCR 8-day exponential moving average is 2.39, which is a Buy signal.
-
The stock price of CNCR is 10.74 while Range Cancer Therapeutics ETF 20-day EMA is 1.02, which makes it a Buy.
-
Range Cancer Therapeutics ETF 50-day exponential moving average is 0.42 while CNCR share price is 10.74, making it a Buy technically.
-
CNCR stock price is 10.74 and Range Cancer Therapeutics ETF 200-day simple moving average is 0.11, creating a Buy signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
-
CNCR Moving Average Covergence Divergence (MACD) indicator is 0.86, suggesting Range Cancer Therapeutics ETF is a Buy
-
Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 39.51, which suggest Range Cancer Therapeutics ETF is oversold
-
The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (10.71 - 12.21), which suggest Range Cancer Therapeutics ETF is a Sell
-
The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (11.51 - 14.29), which suggest Range Cancer Therapeutics ETF is a Sell
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.